Liman Niu

Liman Niu

Auto-generated profile, based on publicly available information

Liman Niu

Shenzhen Institute of Translational Medicine The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital Shenzhen Guangdong China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LNLiman Niu
Liman Niu
FLFangzhou Lou
Fangzhou Lou
YSYang Sun
Yang Sun
LSLibo Sun
Libo Sun
XCXiaojie Cai
Xiaojie Cai
HWHonglin Wang
Honglin Wang
A micropeptide encoded by MIR155HG modulates antigen presentation and suppresses autoinflammation through binding to HSC70.

20 September 2022 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
CWChenguang Wang
Chenguang Wang
HXHaibo Xu
Haibo Xu
XLXinhui Liao
Xinhui Liao
WWWeiming Wang
Weiming Wang
WWWanjun Wu
Wanjun Wu
FSFei Song
Fei Song
Recent studies have demonstrated that hypertension correlates with tumorigenesis and prognosis of clear-cell renal cell carcinoma (ccRCC); however, the underlying molecular mechanisms remain unclear. By analyzing bulk and single-cell RNA sequencing data and experimental examining of surgical excised ccRCC samples, we found that tissue inhibitors of metalloproteinases 3 (TIMP3), a pivotal paracrine factor in suppressing tumor progression, was significantly reduced in the tumor endothelial cells of patients with hypertensive ccRCC. Besides, in tumor xenograft of NCG mouse model, compared with saline normotensive group the expression of TIMP3 was significantly decreased in the angiotensin II–induced hypertension group. Treating human umbilical vein endothelial cells (HUVEC) with the plasma of patients with hypertensive ccRCC and miR-21–5p, elevated in the plasma of patients with hypertensive ccRCC, reduced the expression of TIMP3 compared with normotensive and control littermates. We also found that the inhibition of TIMP3 expression by miR-21–5p was not through directly targeting at 3′UTR of TIMP3 but through suppressing the expression of TGFβ receptor 2 (TGFBR2). In addition, the knockout of TGFBR2 reduced TIMP3 expression in HUVECs through P38/EGR1 (early growth response protein 1) signaling axis. Moreover, via coculture of ccRCC cell lines with HUVECs and mouse tumor xenograft model, we discovered that the TIMP3 could suppress the proliferation and migration of ccRCC. Implications: Overall, our findings shed new light on the role of hypertension in promoting the progression of ccRCC and provide a potential therapeutic target for patients with ccRCC with hypertension.

20 January 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
XLXin Liu
Xin Liu
LNLiman Niu
Liman Niu
LZLiyun Zhang
Liyun Zhang
LJLiqiong Jiang
Liqiong Jiang
KLKaiqing Liu
Kaiqing Liu
JWJiantao Wang
Jiantao Wang
Background: Congenital ectopia lentis (EL) refers to the congenital dysplasia or weakness of the lens suspensory ligament, resulting in an abnormal position of the crystalline lens, which can appear as isolated EL or as an ocular manifestation of a syndrome, such as the Marfan syndrome. The fibrillin‐1 protein encoded by the FBN1 gene is an essential component of the lens zonules. Mutations in FBN1 are the leading causes of congenital EL and Marfan syndrome. Owing to the complexity and individual heterogeneity of FBN1 gene mutations, the correlation between FBN1 mutation characteristics and various clinical phenotypes remains unclear.Methods: This study describes the clinical characteristics and identifies possible causative genes in eight families with Marfan syndrome or isolated EL using Sanger and whole‐exome sequencing.Results: Eight FBN1 mutations were identified in these families, of which three (c.5065G > C, c.1600 T > A, and c.2210G > C) are reported for the first time. Based on in silico analyses, we hypothesized that these mutations may be pathogenic by affecting the fibrillin‐1 protein structure and function.Conclusion: These findings expand the number of known mutations involved in EL and provide a reference for the research on their genotype and phenotype associations.